Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Non Operating Income: 2010-2025

Historic Non Operating Income for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -$3,000.

  • Lifecore Biomedical's Non Operating Income rose 115.52% to $171,000 in Q2 2025 from the same period last year, while for May 2025 it was -$3,000, marking a year-over-year increase of 99.90%. This contributed to the annual value of -$3,000 for FY2025, which is 99.90% up from last year.
  • Per Lifecore Biomedical's latest filing, its Non Operating Income stood at -$3,000 for FY2025, which was up 99.90% from -$3.1 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Non Operating Income ranged from a high of $760,000 in FY2022 and a low of -$11.0 million during FY2021.
  • Moreover, its 3-year median value for Non Operating Income was -$1.2 million (2023), whereas its average is -$1.4 million.
  • In the last 5 years, Lifecore Biomedical's Non Operating Income plummeted by 5,525.13% in 2021 and then skyrocketed by 106.93% in 2022.
  • Over the past 5 years, Lifecore Biomedical's Non Operating Income (MRY) stood at -$11.0 million in 2021, then soared by 106.93% to $760,000 in 2022, then tumbled by 252.50% to -$1.2 million in 2023, then tumbled by 163.33% to -$3.1 million in 2024, then skyrocketed by 99.90% to -$3,000 in 2025.
  • Its Non Operating Income stands at -$3,000 for FY2025, versus -$3.1 million for FY2024 and -$1.2 million for FY2023.